The Department of Health and Human Services (HHS) and the U.S. attorneys for both Southern District of New York and Massachusetts have stepped up their oversight of patient groups’ relationships with pharmaceutical companies advising the groups of possible violation of Medicare’s anti-kickback rules. Read article here…..
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.